Biomatter Designs Company
Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Total Funding:
608000.0
Headquarters:
Vilnius, Vilniaus Apskritis, Lithuania
Funding Status:
Seed
Employee Number:
11-50
Last Funding Type:
Seed
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Last Funding Date:
2021-01-11
Investors Number:
2.0
Founded Date:
2018-01-01
Industry:
Early Drug Development